These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Ulrich-Vinther M Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340 [TBL] [Abstract][Full Text] [Related]
6. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. Goater J; Müller R; Kollias G; Firestein GS; Sanz I; O'Keefe RJ; Schwarz EM J Rheumatol; 2000 Apr; 27(4):983-9. PubMed ID: 10782827 [TBL] [Abstract][Full Text] [Related]
7. Current status of gene therapy for rheumatoid arthritis. Gaddy DF; Robbins PD Curr Rheumatol Rep; 2008 Oct; 10(5):398-404. PubMed ID: 18817645 [TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus as delivery vector for gene therapy--a review. Lu Y Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701 [TBL] [Abstract][Full Text] [Related]
9. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Adriaansen J; Khoury M; de Cortie CJ; Fallaux FJ; Bigey P; Scherman D; Gould DJ; Chernajovsky Y; Apparailly F; Jorgensen C; Vervoordeldonk MJ; Tak PP Ann Rheum Dis; 2007 Sep; 66(9):1143-50. PubMed ID: 17363402 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Adriaansen J; Vervoordeldonk MJ; Tak PP Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530 [TBL] [Abstract][Full Text] [Related]
11. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides. Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302 [TBL] [Abstract][Full Text] [Related]
12. Development of new molecules, vectors and cells for therapy of arthritis. Chernajovsky Y; Vessillier S; Adams G; Gofur Y; Subang MC; Annenkov A; Favorov P; Daly G; Gould D Joint Bone Spine; 2003 Dec; 70(6):474-6. PubMed ID: 14667556 [No Abstract] [Full Text] [Related]
17. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis. Zhang HG; Xie J; Yang P; Wang Y; Xu L; Liu D; Hsu HC; Zhou T; Edwards CK; Mountz JD Hum Gene Ther; 2000 Nov; 11(17):2431-42. PubMed ID: 11096446 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. Bloquel C; Bessis N; Boissier MC; Scherman D; Bigey P Hum Gene Ther; 2004 Feb; 15(2):189-201. PubMed ID: 14975191 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for arthritis. Traister RS; Hirsch R Mod Rheumatol; 2008; 18(1):2-14. PubMed ID: 18176779 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. Auricchio A; O'Connor E; Weiner D; Gao GP; Hildinger M; Wang L; Calcedo R; Wilson JM J Clin Invest; 2002 Aug; 110(4):499-504. PubMed ID: 12189244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]